Literature DB >> 2867770

Determination of the pK values of 5-aminosalicylic acid and N-acetylaminosalicylic acid and comparison of the pH dependent lipid-water partition coefficients of sulphasalazine and its metabolites.

H Allgayer, J Sonnenbichler, W Kruis, G Paumgartner.   

Abstract

Sulphasalazine (SASP), used in the treatment of inflammatory bowel disease, is split into sulphapyridine (SP) and 5-aminosalicylic acid (5-ASA) in the colon. Lower plasma levels of SASP and 5-ASA as compared to those of SP may be due to different absorption rates from the colon because of different pK values and pH dependent lipid-water partition coefficients. In this study we determined the pK values of 5-ASA and its major metabolite, N-acetyl amino-salicylic acid (AcASA), by 13C-NMR spectroscopy and compared the pH dependent apparent benzene-water partition coefficients (Papp) of SASP, SP and 5-ASA with respect to their different plasma levels. The COOH group of 5-ASA had a pK value of 3.0, the -NH3+ group had 6.0, the -OH group 13.9; the -COOH group of AcASA had 2.7 and the -OH group 12.9; The Papp of SASP (0.042 +/- 0.004) and 5-ASA (0.059 +/- 0.01) were significantly lower than that of SP (0.092 +/- 0.03) (at pH 5.5).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2867770

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  Investigation of the degradation mechanism of 5-aminosalicylic acid in aqueous solution.

Authors:  R K Palsmeier; D M Radzik; C E Lunte
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

2.  Superoxide inhibition following different stimuli of respiratory burst and metabolism of aminosalicylates in neutrophils.

Authors:  H Allgayer; S Rang; U Klotz; P Böhne; J Retey; W Kruis; R Gugler
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

3.  Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance: Part 1-Effects on Solubility of Poorly Soluble Drugs.

Authors:  J Martir; T Flanagan; J Mann; N Fotaki
Journal:  AAPS PharmSciTech       Date:  2020-06-26       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.